1. Home
  2. AURA vs LPA Comparison

AURA vs LPA Comparison

Compare AURA & LPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • LPA
  • Stock Information
  • Founded
  • AURA 2007
  • LPA 2013
  • Country
  • AURA United States
  • LPA United States
  • Employees
  • AURA N/A
  • LPA N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • LPA
  • Sector
  • AURA Health Care
  • LPA
  • Exchange
  • AURA Nasdaq
  • LPA Nasdaq
  • Market Cap
  • AURA 370.1M
  • LPA 310.7M
  • IPO Year
  • AURA 2021
  • LPA N/A
  • Fundamental
  • Price
  • AURA $6.34
  • LPA $9.11
  • Analyst Decision
  • AURA Strong Buy
  • LPA
  • Analyst Count
  • AURA 4
  • LPA 0
  • Target Price
  • AURA $22.75
  • LPA N/A
  • AVG Volume (30 Days)
  • AURA 383.6K
  • LPA 10.1K
  • Earning Date
  • AURA 03-24-2025
  • LPA 05-14-2025
  • Dividend Yield
  • AURA N/A
  • LPA N/A
  • EPS Growth
  • AURA N/A
  • LPA N/A
  • EPS
  • AURA N/A
  • LPA N/A
  • Revenue
  • AURA N/A
  • LPA $44,311,428.00
  • Revenue This Year
  • AURA N/A
  • LPA N/A
  • Revenue Next Year
  • AURA N/A
  • LPA N/A
  • P/E Ratio
  • AURA N/A
  • LPA N/A
  • Revenue Growth
  • AURA N/A
  • LPA 22.46
  • 52 Week Low
  • AURA $5.77
  • LPA $6.00
  • 52 Week High
  • AURA $12.38
  • LPA $525.00
  • Technical
  • Relative Strength Index (RSI)
  • AURA 34.98
  • LPA N/A
  • Support Level
  • AURA $5.77
  • LPA N/A
  • Resistance Level
  • AURA $7.73
  • LPA N/A
  • Average True Range (ATR)
  • AURA 0.46
  • LPA 0.00
  • MACD
  • AURA -0.13
  • LPA 0.00
  • Stochastic Oscillator
  • AURA 29.08
  • LPA 0.00

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About LPA Logistic Properties of the Americas

Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns and manages a diversified portfolio of warehouse logistics assets in Central America and the South America. It focuses on modern Class A logistics real estate in high growth and high barrier-to-entry markets that are undersupplied and have low penetration rates.

Share on Social Networks: